Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Pascal Deschatelets Insider Profile
4 Followers
Pascal Deschatelets, CSO at Apellis Pharmaceuticals, holds 1.14M shares in Apellis Pharmaceuticals (Ticker: APLS).
Profitable Transactions
6 out of 6 Profitable Transactions
Average Return
+32.50%
Average return per transaction
Time Frame
Compare to
Insider Holdings
100.00%
A breakdown of Pascal Deschatelets's holdings
Insider Roles
CSO
Roles that Pascal Deschatelets holds in companies
Most Profitable Insider Trade
The most profitable trade made by Pascal Deschatelets
Pascal Deschatelets's Trading History
List of latest transactions for each holding click on a transaction to see Pascal Deschatelets's performance on stock
You May Also Like
Pascal Deschatelets insider profile FAQ
What is the percentage of profitable transactions made by Pascal Deschatelets?
The percentage of profitable transactions made by Pascal Deschatelets is 100%.
What is the average return per transaction made by Pascal Deschatelets?
The average return per transaction made by Pascal Deschatelets is 32.50%.
What stocks does Pascal Deschatelets hold?
Pascal Deschatelets holds: APLS stocks.
What was Pascal Deschatelets’s latest transaction?
Pascal Deschatelets latest transaction was an Uninformative Buy of $92.12K.
What was Pascal Deschatelets's most profitable transaction?
Pascal Deschatelets’s most profitable transaction was an Informative Sell of APLS stock on January 23, 2024. The return on the trade was 43.70%.
What is Pascal Deschatelets's role in Apellis Pharmaceuticals?
Pascal Deschatelets's role in Apellis Pharmaceuticals is CSO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.